Compare AdaptHealth Corp (AHCO) vs Vanguard Mega Cap Growth ETF (MGK) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AdaptHealth Corp vs Vanguard Mega Cap Growth ETF — how do they compare? AdaptHealth Corp trades at $10.05 (market cap $1.38B), while Vanguard Mega Cap Growth ETF trades at $87.16. The key difference: Vanguard Mega Cap Growth ETF is trading nearer its 52-week high, AdaptHealth Corp nearer its low. Which is the better fit depends on your goals.
| AHCO | MGK | |
|---|---|---|
Market Cap | $1.38B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $13.38 | $92.06 |
52-Week Low | $8.68 | $70.70 |
Enterprise Value | $3.33B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.
The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.
MGK trades at $88.29, up 1.47% today, with a bullish technical signal from moving averages but bearish oscillators. The ETF completed a 1:5 stock split in April 2026 and announced a $0.08 dividend for H1-2026. News highlights potential inclusion of SpaceX and emphasizes MGK's low 0.05% expense ratio and heavy concentration in mega-cap tech stocks, which have driven historical outperformance versus the S&P 500.
Outlook remains positive due to exposure to high-growth tech giants, though concentration risk and overbought technicals near-term pose challenges. Long-term growth potential is supported by earnings momentum, but investors face volatility from sector rotations and valuation sensitivity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AdaptHealth Corp
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →About Vanguard Mega Cap Growth ETF
MGK is an ETF that seeks to track the performance of the CRSP US Mega Cap Growth Index. It provides a low-cost, diversified exposure to the largest growth companies in the U.S. stock market. The fund is composed of mega-cap stocks that exhibit key growth factors, including high expected long-term earnings growth, high historical sales and earnings growth, and high return on assets. MGK is typically used by investors seeking long-term capital appreciation from market-leading firms.
Read more on MGK →
